Transdermal permeation of alniditan by iontophoresis: In vitro optimization and human pharmacokinetic data

Pharmaceutical Research

Volumn 13, Issue 9, 1996, Pages 1348-1353

  Jadoul, Anne ^a   Mesens, Jean ^b   Caers, Wim ^b   De Beukelaar, Frank ^b   Crabbe R ^b   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

alniditan; iontophoresis; migraine; transdermal drug delivery

Indexed keywords

ALNIDITAN; SEROTONIN 1D ANTAGONIST;

ADULT; ARTICLE; DRUG DELIVERY SYSTEM; DRUG LABELING; DRUG PENETRATION; DRUG STRUCTURE; DRUG TRANSPORT; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; IONTOPHORESIS; ISOTOPE LABELING; MALE; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANIMALS; BENZOPYRANS; BUFFERS; ELECTRODES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; IONTOPHORESIS; MALE; PROPYLAMINES; PYRIMIDINES; RATS; SKIN ABSORPTION; VASOCONSTRICTOR AGENTS;

EID: 0029955055     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016069816216     Document Type: Article

References (15)

1. B. H. Sage and J. E. Riviere. Model systems iontophoresis-transport efficacity. Adv. Drug Del. Rev. 9:265-287 (1992).
2. B. H. Sage. Iontophoresis, in Encyclopedia of Pharmaceutical Technology. Swarbrick J., Boylan J. C. (Eds), vol. 8 (1993) pp 247-217.
3. S. M. Sims, W. I. Higuchi, and V. Srinivasan. Skin alteration and convective solvent flow effects during iontophoresis: I. Neutral solute transport across human skin. Int. J. Pharm. 69:109-121 (1991).
4. V. Préat and S. Thysman. Transdermal iontophoretic delivery of sufentanil. Int. J. Pharm. 96:189-196 (1993).
5. S. Thysman, C. Tasset, and V. Préat. Transdermal iontophoresis of fentanyl: delivery and mechanistic analysis. Int. J. Pharm. 101:105-113 (1994).
6. H. Schaefer and E. Lamaud. Standardization of experimental models. in Pharmacol. Skin. Schott, B, Shaefer, H. (Eds), vol. 1 (1987) pp 77-80.
7. P. Green, B. Shroot, F. Bernerd, W. R. Pilgrim, and R. H. Guy. In vitro and in vivo iontophoresis of a tripeptide across nude rat skin. J. Controlled Release 20:209-218 (1992).
8. A. Jadoul, C. Hanchard, S. Thysman, and V. Préat. Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin. Int. J. Pharm. 120:221-228 (1995).
9. A. K. Banga and Y. W. Chien. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J. Controlled Release. 7:1-24 (1988).
10. J. Nightingale, J. Sclafani, and T. Kurihara-Bergstrom. Effect of pH on the iontophoretic delivery of ionic compounds. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 17:431-432 (1990).
11. M. B. Delgado-Charro and R. Guy. Iontophoretic delivery of nafarelin across the skin. Int. J. Pharm. 117:165-172 (1995).
12. J. B. Phipps and J. R. Gyory. Transdermal ion migration. Adv. Drug Del. Rev. 9:137-176 (1992).
13. C. Cullander, G. Rao, and R. H. Guy. Why silver/silver chloride? Criteria for iontophoresis electrodes, in Prediction of Percutaneous Penetration, K. R. Brain and V. A. Walters (Eds), STS Publishing, vol. 3, 1993, pp. 381-390.
14. L. L. Wearley, J. C. Liu, and Y. W. Chien. Iontophoresis-facilitated transdermal delivery of verapamil. II. Factors affecting the reversibility of skin permeability. J. Controlled Release 9:231-242 (1989).
15. S. Thysman and V. Préat. In vivo iontophoresis of fentanyl and sufentanil in rats: pharmacokinetics and acute antinociceptive effects. Anesth. Anal. 77:61-66 (1993).